Search

Zodasiran

It was granted an orphan drug designation for the treatment of homozygous familial hypercholesterolemia (HoFH).[L45869]

BT200

[A261491] It is under investigation for the treatment of von Willebrand disease and hemophilia A.[L48156]

BGT-DTDS

It is under investigation for the treatment of dopamine transporter deficiency syndrome (DTDS).

(R)-warfarin

Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways.

(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime

This compound belongs to the phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.

Lomedeucitinib

Lomedeucitinib is under investigation in clinical trial NCT05730725 (A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis).

Idanpramine

Chlorbenzoxamine

Managlinat dialanetil

CS-917 is a novel inhibitor of fructose 1,6-bisphphosphatase (FBPase) which is one of the rate-limiting enzymes of gluconeogenesis.

Trodusquemine

It has demonstrated the ability to stimulate regeneration of heart and multiple other tissues in animal models [A176600].